Icon Public Limited Company

Organisation

South County Business Park, Dublin, Ireland, D18 X5R3

Headquarters

39800

Employees

Health Technology

Industry

Stephen Cutler

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

Price

Target

Icon Public Limited Company (ICLR) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Icon Public Limited Company (ICLR) share price will touch around $144.36 in next 12-months.

Currently 23 wall-street analysts regularly analyze the financials of Icon Public Limited Company on a frequent basis to provide recommendations along with target share price. 23 analysts offering 12-month price forecasts for Icon Public Limited Company (ICLR) have a share price target of $144.36. This median of share price forecast represents a 36.87% upside from the latest price of $105.47 as on 13.03.26.

Icon Public Limited Company (ICLR) Share Price Forecast

Home

US Stocks

Icon Public Limited Company (ICLR)

Icon Public Limited Company Stock Forecast

Icon Public Limited Company Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Icon Public Limited Company (ICLR): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Icon Public Limited Company's share price and its median forecast price. As on 13.03.26, the difference is -12.92%

Icon Public Limited Company Forecast and Target Price

Icon Public Limited Company (ICLR) Share Price Forecast

Icon Public Limited Company (ICLR) Price vs Consensus Price Target

Icon Public Limited Company (ICLR) Share Price Forecast v/s Share Price Today

Icon Public Limited Company (ICLR): Difference between Current Price & Median Forecasted Price

Icon Public Limited Company (ICLR) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price